Morrison Foerster Welcomes Kathleen Kean as Partner in Boston

Kathleen Kean joined Morrison Foerster as a partner in its life sciences transactions and licensing and technology transactions groups in Boston, the firm announced Wednesday.

Kean brings more than 20 years of combined private practice and in-house experience advising biotechnology, pharmaceutical, diagnostics, and medical device companies on complex licensing, commercialization, and multibillion-dollar collaboration and M&A-adjacent transactions. She counsels clients in connection with licensing arrangements, collaboration agreements, pre-clinical, clinical and commercial contracts, mergers and acquisitions, corporate restructuring transactions, and IP migration transactions, the firm said.

Kean joins from Goodwin.

This story was produced by Bloomberg Law Automation.